Providence study show CGP helps cancer patients live longer
--
Patients with advanced cancer who are tested with comprehensive genomic profiling (CGP) at the time of diagnosis and receive targeted therapies live longer than those who receive chemotherapy only, a Providence Genomics-supported study found.